A personalized peptide vaccine slashed prostate-specific antigen levels by as much as 99.6% in some men with advanced ...

Prostate cancer is one of the most common cancers affecting men around the world. It develops in the prostate, a small gland ...

foley catheter leads to TULIP Proposed 5-tiered system found to predict the risk of prostate cancer-specific mortality. A proposed simpler grading system for prostate cancer (PCa) can predict the risk ...

Vanquish uses ultrasound, transurethral and electromagnetically guided thermotherapy to ablate prostate tissue.

Scientists have reported results from an early-stage trial of an immunotherapy drug called VIR-5500. The drug offers new hope ...

MINNEAPOLIS, Dec. 2, 2025 /PRNewswire/ -- Francis Medical, Inc., a privately-held medical device company developing the breakthrough Vanquish® Water Vapor Ablation System for the management of ...

Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to ...

Peer-reviewed findings demonstrate high disease control and quality-of-life preservation, supporting shift toward focal therapy in prostate treatment “The publication of the PRESERVE study in European ...

One of the most common concerns about treating prostate cancer is preserving sexual function and urinary control. For some prostate cancers, newer treatments offering an alternative to radiation and ...

Click to share on Facebook (Opens in new window) Facebook Click to share on X (Opens in new window) X Prostadine is a health supplement that has been creating quite a buzz on the internet in the last ...